Published in Circ Res on August 03, 2001
Signaling pathways in ischemic preconditioning. Heart Fail Rev (2007) 2.26
Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells. Circulation (2010) 1.82
The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration. J Physiol (2002) 1.68
Cardioprotective signaling to mitochondria. J Mol Cell Cardiol (2008) 1.49
Mechanism of cardioprotection by early ischemic preconditioning. Cardiovasc Drugs Ther (2010) 1.41
Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts. J Mol Cell Cardiol (2007) 1.24
Cardioprotection evoked by remote ischaemic preconditioning is critically dependent on the activity of vagal pre-ganglionic neurones. Cardiovasc Res (2012) 1.23
Susceptibility of the heart to ischaemia-reperfusion injury and exercise-induced cardioprotection are sex-dependent in the rat. J Physiol (2005) 1.16
The paradigm of postconditioning to protect the heart. J Cell Mol Med (2007) 1.07
Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization. Life Sci (2007) 1.03
Cardioprotective actions of peptide hormones in myocardial ischemia. Heart Fail Rev (2007) 1.02
Infarct limitation by a protein kinase G activator at reperfusion in rabbit hearts is dependent on sensitizing the heart to A2b agonists by protein kinase C. Am J Physiol Heart Circ Physiol (2008) 0.96
Responses of hypertrophied myocytes to reactive species: implications for glycolysis and electrophile metabolism. Biochem J (2011) 0.96
Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection? Br J Pharmacol (2014) 0.93
Preconditioning-mimetics bradykinin and DADLE activate PI3-kinase through divergent pathways. J Mol Cell Cardiol (2007) 0.90
Signalling pathways and mechanisms of protection in pre- and postconditioning: historical perspective and lessons for the future. Br J Pharmacol (2014) 0.90
Evidence for an intracellular localization of the adenosine A2B receptor in rat cardiomyocytes. Basic Res Cardiol (2011) 0.90
Ischaemic tolerance in aged mouse myocardium: the role of adenosine and effects of A1 adenosine receptor overexpression. J Physiol (2003) 0.89
Nitrite as a mediator of ischemic preconditioning and cytoprotection. Nitric Oxide (2011) 0.88
Hydrogen sulfide-mediated myocardial pre- and post-conditioning. Expert Rev Clin Pharmacol (2011) 0.87
Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery. Basic Res Cardiol (2016) 0.87
Ischemic preconditioning: protection against myocardial necrosis and apoptosis. Vasc Health Risk Manag (2007) 0.86
Opioid-induced cardioprotection. Curr Pharm Des (2014) 0.85
Ischemic conditioning: the challenge of protecting the diabetic heart. Cardiovasc Diagn Ther (2014) 0.85
Morphine and remifentanil-induced cardioprotection: its experimental and clinical outcomes. Korean J Anesthesiol (2011) 0.85
Effect of HEMADO on Level of CK-MB and LDH Enzymes after Ischemia/Reperfusion Injury in Isolated Rat Heart. Bioimpacts (2012) 0.84
Cardioprotection in ischemia/reperfusion injury: spotlight on sphingosine-1-phosphate and bradykinin signalling. Prog Biophys Mol Biol (2010) 0.84
The "Goldilocks Zone" from a redox perspective-Adaptive vs. deleterious responses to oxidative stress in striated muscle. Front Physiol (2014) 0.84
Interactive effects of endogenous morphine, nitric oxide, and ethanol on mitochondrial processes. Arch Med Sci (2010) 0.83
Neural mechanisms of cardioprotection. Physiology (Bethesda) (2014) 0.82
Post-ischemic early acidosis in cardiac postconditioning modifies the activity of antioxidant enzymes, reduces nitration, and favors protein S-nitrosylation. Pflugers Arch (2011) 0.82
Redox signalling and cardioprotection: translatability and mechanism. Br J Pharmacol (2015) 0.81
Myocardial ischemic conditioning: Physiological aspects and clinical applications in cardiac surgery. J Saudi Heart Assoc (2013) 0.81
The antiarrhythmic effect of centrally administered rilmenidine involves muscarinic receptors, protein kinase C and mitochondrial signalling pathways. Br J Pharmacol (2008) 0.80
Cardioprotection acquired through exercise: the role of ischemic preconditioning. Curr Cardiol Rev (2014) 0.79
Vascular endothelial dysfunction in Duchenne muscular dystrophy is restored by bradykinin through upregulation of eNOS and nNOS. Basic Res Cardiol (2011) 0.79
Morphine induces preconditioning via activation of mitochondrial K(Ca) channels. Can J Anaesth (2010) 0.79
Activation of ATP-dependent potassium channels is a trigger but not a mediator of ischaemic preconditioning in pigs. Br J Pharmacol (2003) 0.78
Morphine stimulates nitric oxide release in human mitochondria. J Bioenerg Biomembr (2015) 0.78
Endothelin-1 exerts a preconditioning-like cardioprotective effect against ischaemia/reperfusion injury via the ET(A) receptor and the mitochondrial K(ATP) channel in the rat in vivo. Br J Pharmacol (2005) 0.78
Bradykinin and adenosine receptors mediate desflurane induced postconditioning in human myocardium: role of reactive oxygen species. BMC Anesthesiol (2010) 0.78
Liver ischemia preconditions the heart against ischemia-reperfusion arrhythmias. Iran J Basic Med Sci (2015) 0.78
Origins of the vagal drive controlling left ventricular contractility. J Physiol (2016) 0.77
Oestrogen enhances cardiotoxicity induced by Sunitinib by regulation of drug transport and metabolism. Cardiovasc Res (2015) 0.77
Oral nicorandil recaptures the waned protection from preconditioning in vivo. Br J Pharmacol (2003) 0.75
Morphine-Induced Preconditioning: Involvement of Protein Kinase A and Mitochondrial Permeability Transition Pore. PLoS One (2016) 0.75
Isosteviol Sensitizes sarcKATP Channels towards Pinacidil and Potentiates Mitochondrial Uncoupling of Diazoxide in Guinea Pig Ventricular Myocytes. Oxid Med Cell Longev (2016) 0.75
Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists. Med Res Rev (2016) 0.75
Intrinsic cardiac ganglia and acetylcholine are important in the mechanism of ischaemic preconditioning. Basic Res Cardiol (2017) 0.75
Cardioprotection induced in a mouse model of neuropathic pain via anterior nucleus of paraventricular thalamus. Nat Commun (2017) 0.75
Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation (1991) 4.30
Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res (2000) 3.19
Ischaemic preconditioning: can the protection be bottled? Lancet (1993) 2.33
Neural mechanisms generating respiratory pattern in mammalian brain stem-spinal cord in vitro. I. Spatiotemporal patterns of motor and medullary neuron activity. J Neurophysiol (1990) 2.32
Ischemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol (2000) 2.28
Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation (1999) 2.20
Molecular cloning of the human gene, PNKP, encoding a polynucleotide kinase 3'-phosphatase and evidence for its role in repair of DNA strand breaks caused by oxidative damage. J Biol Chem (1999) 2.15
Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol (1997) 2.15
Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation (1992) 2.08
Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol (1994) 2.04
Myocardial protection by remote ischaemic pre-conditioning is abolished in sulphonylurea-treated diabetics undergoing coronary revascularisation. Acta Anaesthesiol Scand (2014) 2.02
Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol (1985) 2.00
Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res (1995) 1.75
Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs. J Am Coll Cardiol (1998) 1.69
Low-frequency spectral power of heart rate variability is not a specific marker of cardiac sympathetic modulation. Anesthesiology (1995) 1.65
Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc Res (1994) 1.62
Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery. A model of short-term hibernation. Circ Res (1992) 1.54
Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial. Acta Anaesthesiol Scand (2011) 1.53
Differential gene expression between visceral and subcutaneous fat depots. Horm Metab Res (2003) 1.50
Acute ethanol exposure fails to elicit preconditioning-like protection in in situ rabbit hearts because of its continued presence during ischemia. J Am Coll Cardiol (2001) 1.49
No confirmation for a causal role of volume-regulated chloride channels in ischemic preconditioning in rabbits. J Mol Cell Cardiol (2000) 1.49
Involvement of hepatocyte growth factor in kidney development. Dev Biol (1994) 1.47
Neurogenesis of respiratory rhythm and pattern: emerging concepts. Am J Physiol (1990) 1.44
Left ventricular unloading during reperfusion does not limit myocardial infarct size. Circulation (1990) 1.43
Inhibition of coronary blood flow by a vascular waterfall mechanism. Circ Res (1975) 1.41
Development of short-term myocardial hibernation. Its limitation by the severity of ischemia and inotropic stimulation. Circulation (1993) 1.41
Positron emission tomography analysis of [1-(11)C] acetate kinetics in short-term hibernating myocardium. Circulation (1998) 1.40
Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. Am J Physiol (1990) 1.39
Transcutaneous pCO2-monitoring for the evaluation of the anaerobic threshold. Comparison to lactate and ventilatory thresholds. Int J Sports Med (1993) 1.38
Unique cardioprotective action of the new calcium antagonist mibefradil. Circulation (1999) 1.38
Intravenous co-infusion of adenosine and norepinephrine preconditions the heart without adverse hemodynamic effects. J Thorac Cardiovasc Surg (1997) 1.38
Signal transduction of ischemic preconditioning. Cardiovasc Res (2001) 1.38
Reduction of myocardial ischemic injury with oxygen-derived free radical scavengers. Surgery (1983) 1.38
[The pathophysiology of myocardial circulation. I. Adaptation to myocardial ischemia (the "hibernating" myocardium)]. Dtsch Med Wochenschr (1994) 1.37
Preconditioning: state of the art myocardial protection. Cardiovasc Res (1993) 1.35
Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol (1999) 1.33
An effective method for axillary bud culture and RAPD analysis of cloned plants in tetraploid black locust. Plant Cell Rep (2003) 1.31
Ischemic preconditioning protects against infarction in rat heart. Am J Physiol (1992) 1.30
Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp110RB) in osteosarcomas and synovial sarcomas. Oncogene Res (1989) 1.30
Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am J Physiol (1994) 1.29
Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation (1991) 1.29
Pulmonary capillary pressure: a review. Crit Care Med (1992) 1.27
Partitioning of the 2-microm circle plasmid of Saccharomyces cerevisiae. Functional coordination with chromosome segregation and plasmid-encoded rep protein distribution. J Cell Biol (2000) 1.26
Xanthine oxidase: a critical mediator of myocardial injury during ischemia and reperfusion? Acta Physiol Scand Suppl (1986) 1.26
Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology (1997) 1.26
Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. Cardiovasc Res (1994) 1.24
The H89 cAMP-dependent protein kinase inhibitor blocks Plasmodium falciparum development in infected erythrocytes. Eur J Biochem (2001) 1.23
Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol (1994) 1.23
Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J Mol Cell Cardiol (1997) 1.22
Ischemic preconditioning: from basic mechanisms to clinical applications. Pharmacol Ther (2000) 1.21
Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol (1995) 1.18
Identification and validation of a major QTL conferring crown rot resistance in hexaploid wheat. Theor Appl Genet (2009) 1.18
Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation (1991) 1.16
G protein beta3 subunit 825T allele and enhanced coronary vasoconstriction on alpha(2)-adrenoceptor activation. Circ Res (1999) 1.15
Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries. Circulation (1999) 1.14
Role of connexin 43 in ischemic preconditioning does not involve intercellular communication through gap junctions. J Mol Cell Cardiol (2004) 1.13
Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. Am J Physiol (1994) 1.12
Ischemic preconditioning in pigs: a graded phenomenon: its relation to adenosine and bradykinin. Circulation (1998) 1.12
Adenosine and the anti-infarct effects of preconditioning. Cardiovasc Res (1993) 1.11
Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation. Am J Physiol Heart Circ Physiol (2000) 1.10
Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol (2000) 1.10
Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart. Cardiovasc Res (1993) 1.08
Mild hypothermia reduces infarct size in the beating rabbit heart: a practical intervention for acute myocardial infarction? Basic Res Cardiol (1998) 1.08
Coronary microembolization. J Am Coll Cardiol (2000) 1.07
Protecting the acutely ischemic myocardium beyond reperfusion therapies: are we any closer to realizing the dream of infarct size elimination? Arch Mal Coeur Vaiss (2007) 1.06
alpha 1-adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res (1994) 1.05
Ischemic preconditioning depends on interaction between mitochondrial KATP channels and actin cytoskeleton. Am J Physiol (1999) 1.05
The 2 micrometer plasmid stability system: analyses of the interactions among plasmid- and host-encoded components. Mol Cell Biol (1998) 1.04
Infarct limitation of the second window of protection in a conscious rabbit model. Cardiovasc Res (1996) 1.04
Free radical-producing enzyme, xanthine oxidase, is undetectable in human hearts. Am J Physiol (1987) 1.04
Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs. Circ Res (1987) 1.04
Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK. Circ Res (2000) 1.03
Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning. Circ Res (1994) 1.03
Elimination of exercise-induced regional myocardial dysfunction by a bradycardiac agent in dogs with chronic coronary stenosis. Circulation (1987) 1.03
Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction. Circulation (1993) 1.02
Ischaemic preconditioning: present position and future directions. Cardiovasc Res (1998) 1.02
Myocardial protection by insulin is dependent on phospatidylinositol 3-kinase but not protein kinase C or KATP channels in the isolated rabbit heart. Basic Res Cardiol (1999) 1.02
Infarct size limitation by the xanthine oxidase inhibitor, allopurinol, in closed-chest dogs with small infarcts. Cardiovasc Res (1985) 1.01
Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia. Cardiovasc Res (1998) 1.01